Heterogeneity of the efficacy of the 23-valent pneumococcal polysaccharide vaccine caused by various underlying conditions of chronic pulmonary disease in older patients: prospective cohort study

Objective To determine the ideal conditions for use of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in older outpatients with chronic pulmonary diseases.Design Prospective cohort study.Participants 1378 outpatients with chronic pulmonary diseases ≥60 years of age.Intervention Participan...

Full description

Saved in:
Bibliographic Details
Main Authors: Satoshi Morita, Satoshi Inoue, Takashi Sato, Yoshiaki Ishigatsubo, Shunsaku Mizushima, Yuji Watanuki, Tetsuji Kaneko, Naoki Miyazawa, Takeshi Kaneko, Yutaka Natsumeda
Format: Article
Language:English
Published: BMJ Publishing Group 2011-09-01
Series:BMJ Open
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items